LENZ Therapeutics, Inc. ($LENZ)
Chevallard Daniel R. โ Chief Financial Officer
Shares
7,500
Price
$8.57
Total Value
$64,275.00
P&L
-2.0% ($1,275.00)
Nearby Earnings
Mar 18, 2026
EPS:Est: -0.91
Revenue:Est: $3.09M
Mar 24, 2026
EPS:Est: -0.91
Revenue:Est: $3.09M
Transaction Details
| Insider | Chevallard Daniel R. |
|---|---|
| Title | Chief Financial Officer |
| Transaction Date | Mar 27, 2026 |
| Transaction Code | P Purchase |
| Acquired/Disposed | Acquired |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Mar 30, 2026 |
| Shares Purchased | 7,500 |
| Price per Share | $8.57 |
| Total Value | $64,275.00 |
| Shares Owned After | 12,886 |
| Derivative | No |
| Accession Number | 0001706176-26-000004 |
| Document | View SEC Filing |